When was Cube Biotech founded?

Cube Biotech was founded in 2012 and raised its 1st funding round within a year of its incorporation.

Where is Cube Biotech located?

Cube Biotech is headquartered in Monheim, Germany.

Which legal entities is Cube Biotech associated with?

Cube Biotech is associated with Cube Biotech Gmbh.

How many employees does Cube Biotech have?

As of Aug 31, 2026, the latest employee count at Cube Biotech is 58.

Is Cube Biotech a funded company?

Cube Biotech is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Dec 2012.

When was the latest funding round of Cube Biotech?

Cube Biotech's latest funding was a $***** Series A round on Dec 2012, with participation from 1 investor.

Where does Cube Biotech rank among its competitors?

Cube Biotech ranks 24th amongst 173 active competitors, of which 30 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Arzeda, which secured $4.51M in Aug, 2025.

Who are the top competitors of Cube Biotech?

Cube Biotech's top competitors include Nautilus Biotechnology, Somalogic and Biognosys. Among them, Arzeda secured the most recent funding round in August, 2025.

Cube Biotech - 2026 Company Profile, Team, Funding, Competitors & Financials

Cube Biotech is an acquired company based in Monheim (Germany), founded in 2012 by Frank Schaefer. It operates as a Provides services for membrane protein research.. Cube Biotech has raised an undisclosed amount in funding from Creathor Venture. The company has 173 active competitors, including 30 funded and 25 that have exited. Its top competitors include companies like Nautilus Biotechnology, Somalogic and Biognosys.

Company Details

Cube Biotech provide services to the pharmaceutical community that enables the analysis of membrane protein structure and function. Services include membrane protein expression, purification, and crystallization. Also produces chromatography materials for protein purification which includes protein-specific affinity matrices.

Website: cube-biotech.com/
Social

Key Metrics

Founded Year

2012

Location

Monheim, Germany

Stage

Acquired

Latest Funding Round

Series A, Dec 2012, $*****

Investors

Creathor Venture & 6 more

Ranked

24^th among 173 active competitors

Employee Count

58 as on Aug 31, 2026

Similar Companies

Nautilus Biotechnology & 233 more

Exit Details

Acquired by ARCHIMED (Nov 03, 2021)

View Cube Biotech's full profile

Cube Biotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Cube Biotech Gmbh CIN: HRB69224 , Germany, Active	Dec 10, 2012	-	16 (As on Dec 31, 2020)

Cube Biotech got acquired by ARCHIMED on Nov 03, 2021.

Click here to take a look at Cube Biotech's acquisition in detail

Cube Biotech has raised funding over 1 round. Its latest funding round was a Series A round on Dec 2012 for $*****. 1 investor participated in its latest round. Cube Biotech has 1 institutional investor and 6 angel investors.

Here is the list of recent funding rounds of Cube Biotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 2012	7207476	Series A	9010607	3324094	6160640	3059862

Access funding benchmarks and valuations. Sign up today!

View details of Cube Biotech's funding rounds and investors

The founders of Cube Biotech is Frank Schaefer.

Here are the details of Cube Biotech's key team members:

Frank Schaefer: Founder of Cube Biotech.

View details of Cube Biotech's Founder profiles and Board Members

Cube Biotech's employee count trend

Cube Biotech has 58 employees as of Aug 26. Here is Cube Biotech's employee count trend over the years:

Uncover Cube Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cube Biotech include Nautilus Biotechnology, Somalogic and Biognosys. Here is the list of Top 10 competitors of Cube Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nautilus Biotechnology 2016, Seattle (United States), Public	Developer of proteomics platform for drug development	$453M	Vulcan, Bain Capital Life Sciences & 8 others	65/100
2nd	Somalogic 1999, Boulder (United States), Acquired	Developer of protein-based assays for life science research	$664M	ProQuest Investments, ICarbonX & 27 others	64/100
3rd	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Syngenta Group, Zurcher Kantonalbank & 6 others	63/100
4th	Arzeda 2008, Seattle (United States), Series B	Developer of enzyme design technology to bridge the gap by creating synthetic enzymes	$95.2M	OS Fund, Conti Ventures & 22 others	59/100
5th	A-Alpha Bio 2017, Seattle (United States), Series A	Developer of cell-based tool for the measurements of protein interactions	$45.2M	Xontogeny, OS Fund & 15 others	57/100
6th	Mursla 2017, London (United Kingdom), Seed	Provider of diagnostic device for cancer detection	$547K	Future Fund, TA Ventures & 26 others	55/100
7th	ProteinSimple 2004, San Jose (United States), Acquired	Provider tools to help researchers with protein analysis	$94.3M	Lansing Brown Investments, Royal Bank of Canada ... & 10 others	54/100
8th	Amunix 2006, Mountain View (United States), Acquired	Developer of peptide-based therapeutics	$201M	Omega Funds, Frazier Healthcare Partners ... & 18 others	49/100
9th	Dynamic Biosensors 2011, Planegg (Germany), Acquired	Provides solutions for label-free molecular interaction and biophysical analysis	$5.83M	Rurode, UVC Partners & 19 others	49/100
10th	Akonni 2003, Frederick (United States), Series C	Molecular diagnostics and sample prep solutions for high-quality nucleic acid purification	$39.7M	Righton, Choosemaryland.org & 5 others	49/100
24th	Cube Biotech 2012, Monheim (Germany), Acquired	Provides services for membrane protein research.	-	Creathor Venture & 6 others	37/100